Cargando…

Drug Discovery for Mycobacterium tuberculosis Using Structure-Based Computer-Aided Drug Design Approach

Developing new, more effective antibiotics against resistant Mycobacterium tuberculosis that inhibit its essential proteins is an appealing strategy for combating the global tuberculosis (TB) epidemic. Finding a compound that can target a particular cavity in a protein and interrupt its enzymatic ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ejalonibu, Murtala A., Ogundare, Segun A., Elrashedy, Ahmed A., Ejalonibu, Morufat A., Lawal, Monsurat M., Mhlongo, Ndumiso N., Kumalo, Hezekiel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703488/ https://www.ncbi.nlm.nih.gov/pubmed/34948055 http://dx.doi.org/10.3390/ijms222413259

Ejemplares similares

Ni(2+) and Cu(2+) complexes of N-(2,6-dichlorophenyl)-N-mesityl formamidine dithiocarbamate structural and functional properties as CYP3A4 potential substrates
por: Oladipo, Segun D., et al.
Publicado: (2023)

Allostery Inhibition of BACE1 by Psychotic and Meroterpenoid Drugs in Alzheimer’s Disease Therapy
por: Ugbaja, Samuel C., et al.
Publicado: (2022)

Understanding the Hsp90 N-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)
por: Magwenyane, Ayanda M., et al.
Publicado: (2020)

Design of New Schiff-Base Copper(II) Complexes: Synthesis, Crystal Structures, DFT Study, and Binding Potency toward Cytochrome P450 3A4
por: Yusuf, Tunde L., et al.
Publicado: (2021)

In Silico Drug Repurposing Approach: Investigation of Mycobacterium tuberculosis FadD32 Targeted by FDA-Approved Drugs
por: Ngidi, Nolwazi Thobeka Portia, et al.
Publicado: (2022)

Theory and Applications of Covalent Docking in Drug Discovery: Merits and Pitfalls
por: Kumalo, Hezekiel Mathambo, et al.
Publicado: (2015)

Impact of Drug Repurposing on SARS-Cov-2 Main Protease
por: Ndagi, Umar, et al.
Publicado: (2023)

Heat Shock Protein 90 (HSP90) Inhibitors as Anticancer Medicines: A Review on the Computer-Aided Drug Discovery Approaches over the Past Five Years
por: Magwenyane, Ayanda M., et al.
Publicado: (2022)

In Silico Drug Repurposing of FDA-Approved Drugs Highlighting Promacta as a Potential Inhibitor of H7N9 Influenza Virus
por: Mtambo, Sphamandla E., et al.
Publicado: (2022)

Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor Design
por: Mtambo, Sphamadla E., et al.
Publicado: (2021)

Metal complexes in cancer therapy – an update from drug design perspective
por: Ndagi, Umar, et al.
Publicado: (2017)

Computer-aided drug discovery
por: Bajorath, Jürgen
Publicado: (2015)

How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery
por: Bhagwat, Amala, et al.
Publicado: (2022)

Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening
por: Grzelak, Edyta M., et al.
Publicado: (2019)

Computational studies of potential antiviral compounds from some selected Nigerian medicinal plants against SARS-CoV-2 proteins
por: Ibeh, Raymond C., et al.
Publicado: (2023)

Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis
por: Kingdon, Alexander D.H., et al.
Publicado: (2021)

Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors
por: Mushebenge, Aganze Gloire-Aimé, et al.
Publicado: (2023)

Antibiotic resistance: bioinformatics-based understanding as a functional strategy for drug design
por: Ndagi, Umar, et al.
Publicado: (2020)

Computer-Aided Drug Discovery in Plant Pathology
por: Shanmugam, Gnanendra, et al.
Publicado: (2017)

An integrated computational approach towards novel drugs discovery against polyketide synthase 13 thioesterase domain of Mycobacterium tuberculosis
por: Altharawi, Ali, et al.
Publicado: (2023)

Mycobacterium tuberculosis infection in intravenous drug users recently diagnosed with HIV/AIDS
por: Popa, Ionuț, et al.
Publicado: (2013)

Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery
por: Namouchi, Amine, et al.
Publicado: (2017)

Marine Drug Discovery through Computer-Aided Approaches
por: Gaudêncio, Susana P., et al.
Publicado: (2023)

Applications of machine learning in computer-aided drug discovery
por: Turzo, SM Bargeen Alam, et al.
Publicado: (2022)

Editorial: Computer-aided drug design: Drug discovery, computational modelling, and artificial intelligence
por: Ye, Fei, et al.
Publicado: (2022)

Tools to Alleviate the Drug Resistance in Mycobacterium tuberculosis
por: Rabaan, Ali A., et al.
Publicado: (2022)

Pangenome Analysis of Mycobacterium tuberculosis Reveals Core-Drug Targets and Screening of Promising Lead Compounds for Drug Discovery
por: Dar, Hamza Arshad, et al.
Publicado: (2020)

Impact of the R292K Mutation on Influenza A (H7N9) Virus Resistance towards Peramivir: A Molecular Dynamics Perspective
por: Mtambo, Sphamandla E., et al.
Publicado: (2022)

Editorial: Drug-resistant Mycobacterium tuberculosis
por: Boshoff, Helena I. M., et al.
Publicado: (2023)

Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum
por: Sarathy, Jansy P., et al.
Publicado: (2018)

Targeting Energy Metabolism in Mycobacterium tuberculosis, a New Paradigm in Antimycobacterial Drug Discovery
por: Bald, Dirk, et al.
Publicado: (2017)

Enhancing Hit Identification in Mycobacterium tuberculosis Drug Discovery Using Validated Dual-Event Bayesian Models
por: Ekins, Sean, et al.
Publicado: (2013)

Mechanism of Inhibition of Hsp90 Dimerization by Gyrase B Inhibitor Coumermycin A1 (C–A1) Revealed by Molecular Dynamics Simulations and Thermodynamic Calculations
por: Cele, Favourite N., et al.
Publicado: (2016)

Critical discussion on drug efflux in Mycobacterium tuberculosis
por: Remm, Sille, et al.
Publicado: (2021)

SWEETLEAD: an In Silico Database of Approved Drugs, Regulated Chemicals, and Herbal Isolates for Computer-Aided Drug Discovery
por: Novick, Paul A., et al.
Publicado: (2013)

Computer-Aided Drug Design Boosts RAS Inhibitor Discovery
por: Wang, Ge, et al.
Publicado: (2022)

Computer-Aided Discovery of New Solubility-Enhancing Drug Delivery System
por: Mizera, Mikołaj, et al.
Publicado: (2020)

Mycobacterium tuberculosis Complex Drug Resistance in Italy
por: Migliori, Giovanni B., et al.
Publicado: (2004)

Bioenergetics of Mycobacterium: An Emerging Landscape for Drug Discovery
por: Iqbal, Iram Khan, et al.
Publicado: (2018)

Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis
por: Kaur, Divneet, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0f3i8ja9g99c7sd5p9nf6aeqfe